Condition: IDA - Iron Deficiency Anemia · Anemia · Iron Deficiency Anemia · Sponsor: Children's Hospital Los Angeles
This is a trial with an observational and an interventional arm, in patients with moderate to severe anemia and control subjects. The main purposes of this study is to phenotype the scope of neurocognitive deficits from iron deficiency anemia (IDA) in adult women, determine derangements in cerebral perfusion, vascular reactivity, functional connectivity, and blood brain barrier permeability in adult-onset IDA and relate them to neurocognitive deficits, as well as determine the reversibility and durability of both the physiologic and neurocognitive derangements by iron replacement therapy. All eligible subjects will be asked to provide informed consent before participating in the study.
This description comes directly from the study's public registry record.
Silvie Suriany, MSc · 323-361-4783 · anemia@chla.usc.edu
Always discuss trial participation with your own doctor first.
| City of Hope Blood Donor Center | Duarte, California, United States | Not Yet Recruiting |
| Cedar Sinai Blood Bank | Los Angeles, California, United States | Not Yet Recruiting |
| Children's Hospital Los Angeles | Los Angeles, California, United States | Recruiting |
| University of California, Los Angeles Blood Donor Center | Los Angeles, California, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05929729